Yıldız, F., and B. Öksüzoğlu. “Efficacy and Toxicity of Everolimus Plus Exemestane in Third and Later Lines Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer”. Journal of Surgery and Medicine, vol. 4, no. 6, June 2020, pp. 443-6, doi:10.28982/josam.745731.